首页> 外文OA文献 >Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma

【2h】

Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma

机译：短效β2激动剂的支气管可逆性预测了对支气管哮喘患者的吸入皮质类固醇的长效β2激动剂给予FEV1的反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
AKIHIKO OHWADA; KEI INAMI; EMI ONUMA; MARIKO MATSUMOTO-YAMAZAKI; RYO ATSUTA; KAZUHISA TAKAHASHI;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination. [J] . Angus R, Reagon R, Cheesbrough A International journal of clinical practice . 2005,第2期

机译：在哮喘患者中，短效β2受体激动剂和口服皮质类固醇激素的使用是同时使用倍氯米松和长效β2受体激动剂或沙美特罗/丙酸氟替卡松联合使用。
2. The effects of long-acting β2-agonists plus inhaled corticosteroids for early reversibility in patients with airway obstruction [J] . Sevket Ozkaya, Adem Dirican, Tibel Tuna Journal of Thoracic Disease . 2013,第4期

机译：长效β2-激动剂加吸入糖皮质激素对气道阻塞患者早期可逆性的影响
3. Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma [J] . Eric D Bateman, Christopher O’Brien, Paul Rugman, Drug Design, Development and Therapy . 2018,第InaProgress期

机译：CRTh2拮抗剂AZD1981作为特应性哮喘患者吸入性糖皮质激素和长效β2受体激动剂的附加疗法的疗效和安全性
4. Systemic Corticosteroid Treatment Reduces Bronchial Mucosal Activation of Activator Protein-1 (AP-1) Components In Cortlcosterold Sensitive, but Not Resistant Asthmatics [C] . T.-K. Loke, K.H. Mallett, J. Ratoff, Collegium Internationale Allergologicum . 2007

机译：系统皮质类固醇处理可降低Cortlcosterollold敏感的活化剂蛋白-1（AP-1）组分的支气管粘膜活化，但不能抵抗哮喘
5. Inhaler device, administration technique and adherence to inhaled corticosteroids among asthmatics. [D] . Battle, Kayleigh Aleis. 2010

机译：哮喘患者的吸入器设备，给药技术和对吸入性糖皮质激素的依从性。
6. Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma [O] . AKIHIKO OHWADA, KEI INAMI, EMI ONUMA, -1

机译：支气管哮喘患者中支气管可逆性与短效β2受体激动剂一起预测长效β2受体激动剂与吸入长效β2受体激动剂的FEV1反应
7. Is the increase in bronchial responsiveness or FEV1 shortly after cessation ofβ2 -agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting β2-agonists [O] . VAN SCHAYCK C.P., CLOOSTERMAN S.G.M., BIJL-HOFLAND I.D., 2002

机译：β2-激动剂停止后不久支气管反应性或FEV1的增加是否反映了过敏性哮喘患者疾病的真正恶化？短效和长效β2-激动剂的比较

Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma

著录项

引文网络

相似文献

相关主题

期刊订阅